Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,265
datasets available to search
ShareScore release 0.9.0
Dataset results
1,265 results for “ATOPIC DERMATITIS”
An Ascending Multiple Dose Study of VTP-38543 in Adult Participants With Mild to Moderate Atopic Dermatitis
ClinicalTrials.gov study NCT02655679. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Efficacy and Safety of Nemolizumab in Subjects With Moderate-to-Severe Atopic Dermatitis
ClinicalTrials.gov study NCT03985943. IPD Sharing: NO. Countries: 14. Publications: 4.
Long-term Safety and Efficacy Study of Lebrikizumab (LY3650150) in Participants With Moderate-to-Severe Atopic Dermatitis (ADjoin)
ClinicalTrials.gov study NCT04392154. IPD Sharing: YES. Countries: 16. Publications: 2.
A Study of Baricitinib (LY3009104) in Participants With Moderate to Severe Atopic Dermatitis
ClinicalTrials.gov study NCT03559270. IPD Sharing: YES. Countries: 3. Publications: 2.
A Study to Evaluate Upadacitinib in Adolescents and Adults With Moderate to Severe Atopic Dermatitis (Measure Up 2)
ClinicalTrials.gov study NCT03607422. IPD Sharing: YES. Countries: 23. Publications: 14.
Evaluation of the Efficacy and Safety of Lebrikizumab (LY3650150) in Moderate to Severe Atopic Dermatitis
ClinicalTrials.gov study NCT04178967. IPD Sharing: YES. Countries: 8. Publications: 11.
Maximal Use Study of Tapinarof Cream, 1% in Pediatric Subjects With Extensive Atopic Dermatitis
ClinicalTrials.gov study NCT05186805. IPD Sharing: NO. Countries: 2. Publications: 12.
A Study of Lebrikizumab (LY3650150) in Combination With Topical Corticosteroids in Japanese Participants With Moderate-to-Severe Atopic Dermatitis
ClinicalTrials.gov study NCT04760314. IPD Sharing: YES. Countries: 1. Publications: 1.
Evaluation of the Efficacy and Safety of Lebrikizumab (LY3650150) in Moderate to Severe Atopic Dermatitis (ADvocate1)
ClinicalTrials.gov study NCT04146363. IPD Sharing: YES. Countries: 10. Publications: 11.
Study of Dupilumab (REGN668/SAR231893) Monotherapy Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis
ClinicalTrials.gov study NCT02277769. IPD Sharing: Not stated. Countries: 11. Publications: 18.
Efficacy and Safety Study of Apremilast in Subjects With Moderate to Severe Atopic Dermatitis
ClinicalTrials.gov study NCT02087943. IPD Sharing: YES. Countries: 3. Publications: 1.
A Study to Assess the Safety and Efficacy of Etrasimod in Subjects With Moderate-to-Severe Atopic Dermatitis
ClinicalTrials.gov study NCT04162769. IPD Sharing: NO. Countries: 3. Publications: 1.
PLINK breed data showing SLAMF1 is associated with canine atopic dermatitis
Open the record for dataset details and reuse information.
Dataset for the analysis of the association of atopic dermatitis(AD) symptom with air pollution and weather
<p>This dataset includes atopic dermatitis(AD) symptom, air pollution, weather data on a daily bases. The dataset was made for the analyses of the association of AD symptom in children with air pollution and weather. 177 AD patients <6 years old from the Seoul Metropolitan Area in Korea were enrolled and followed for 17 months between August 2013 and December 2014.</p> <p>Definition of symptom presence: Parents or guardians were instructed to record the extent of itching, sleep disturbance, erythema, dryness, oozing, and edema on a scale of 0 to 4 by using smartphone-adjusted symptom diary. The presence of AD symptoms was determined when a symptom score was 2 points or more for both itching and sleep disturbance scores, accompanied by at least 2 points of the sum of the following symptoms: erythema, dryness, edema, or oozing. </p>
Transcriptomics characterization of Psoriaris, Atopic dermatitis and Pityriasis Rubra Pilaris
Open the record for dataset details and reuse information.
Multimedia mixed reality interactive shared decision-making game in children with moderate to severe atopic dermatitis, a pilot study
<p><strong>Multimedia mixed reality interactive shared decision-making game in children with moderate to severe atopic dermatitis, a pilot study</strong></p>
Multi-antigen imaging data of skin tissue samples from cutaneous T cell lymphoma, atopic dermatitis, and psoriasis patients
<h1>Data</h1> <p>Multi-antigen imaging data for 69 skin tissue samples (21 cutaneous T cell lymphoma (CTCL), 23 atopic dermatitis (AD), and 25 pseudolymphoma (PSO)), obtained from 27 patients (8 CTCL, 7 AD, 12 PSO) treated at the University Hospital Erlangen. Each sample contains at least 36 protein channels, each of resolution 512 X 512 pixels. The data were generated using multi-epitope ligand cartography (MELC) (https://doi.org/10.1038/nbt1250, https://doi.org/10.1007/3-540-36459-5_8).</p> <h1>Metadata</h1> <p>For each sample, we information on sex, age, and condition of the corresponding patient. Samples and patients are numbered as S01 through S69 and P01 through P27, respectively.</p> <h1>Structure of the repository</h1> <ul> <li>The file <strong>metadata.csv</strong> contains the metadata.</li> <li>The archive <strong>data.zip</strong> contains one directory for each sample, named with the sample numbers S01 through S69.</li> <li>The directories for the individual samples contain images named<strong> <marker>-<flourescent protein>.tif</strong>, where <marker> is the name of the quantified protein marker and <flourescent protein> is the name of the flourescent protein that was used for image acquisition.</li> </ul> <p> </p> <p> </p>
Adhesive Antibacterial Moisturizing Nanostructured Skin Patch for Sustainable Development of Atopic Dermatitis Treatment in Humans [Swelling studies]
<p>Adhesive Antibacterial Moisturizing Nanostructured Skin Patch [Swelling studies]</p>
Long-term Safety and Efficacy of Nemolizumab With Moderate-to-severe Atopic Dermatitis
ClinicalTrials.gov study NCT03989206. IPD Sharing: NO. Countries: 22. Publications: 2.
A Single Ascending Dose Study in Healthy Participants and Multiple Ascending Dose Study of CNTO 7160 in Participants With Asthma and Participants With Atopic Dermatitis
ClinicalTrials.gov study NCT02345928. IPD Sharing: Not stated. Countries: 2. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.